Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) has been assigned an average recommendation of “Hold” from the twelve analysts that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $5.35.
A number of research analysts have weighed in on DH shares. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Barclays decreased their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a research note on Monday, March 3rd. Stephens started coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target for the company. Finally, The Goldman Sachs Group decreased their price target on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th.
Read Our Latest Stock Analysis on Definitive Healthcare
Institutional Trading of Definitive Healthcare
Definitive Healthcare Price Performance
NASDAQ:DH opened at $2.59 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a market cap of $292.44 million, a PE ratio of -0.84, a PEG ratio of 4.06 and a beta of 1.51. Definitive Healthcare has a 52-week low of $2.55 and a 52-week high of $8.35. The stock has a 50-day simple moving average of $4.34 and a 200 day simple moving average of $4.37.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. On average, sell-side analysts expect that Definitive Healthcare will post 0.16 EPS for the current fiscal year.
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Articles
- Five stocks we like better than Definitive Healthcare
- The 3 Best Blue-Chip Stocks to Buy Now
- How to Build the Ultimate Everything ETF Portfolio
- Investing In Automotive Stocks
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.